• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $UNM

    Unum Group

    Subscribe to $UNM
    $UNM
    Accident &Health Insurance
    Finance

    Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, and Poland. It operates through Unum US, Unum International, Colonial Life, and Closed Block segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products. It also provides group pension, individual life and corporate-owned life insurance, reinsurance pools and management operations, and other products. The company sells its products primarily to employers for the benefit of employees. Unum Group sells its products through field sales personnel, independent brokers, and consultants, as well as independent contractor agency sales force. The company was founded in 1848 and is based in Chattanooga, Tennessee.

    IPO Year:

    Exchange: NYSE

    Website: unum.com

    Peers

    $AFL

    Recent Analyst Ratings for Unum Group

    DatePrice TargetRatingAnalyst
    3/5/2025$108.00Mkt Perform → Strong Buy
    Raymond James
    1/23/2025$91.00Outperform
    BMO Capital Markets
    1/7/2025$74.00 → $79.00Overweight → Neutral
    Analyst
    11/14/2024$67.00 → $84.00In-line → Outperform
    Evercore ISI
    9/5/2024$73.00Overweight
    Barclays
    7/11/2024$57.00Overweight
    Piper Sandler
    1/3/2024$55.00Neutral → Overweight
    JP Morgan
    4/25/2023$57.00Overweight
    Wells Fargo
    3/20/2023$44.00 → $50.00Hold → Buy
    Jefferies
    3/15/2023$49.00 → $53.00Neutral → Buy
    Citigroup
    See more ratings